D Schenk - Nature Reviews Neuroscience, 2002 - go.gale.com
The agents that are available at present for the management of Alzheimer's disease treat only the symptoms of neurodegeneration and, at best, result in modest, short-term …
D Schenk - Nature Reviews Neuroscience, 2002 - search.ebscohost.com
The agents that are available at present for the management of Alzheimer's disease treat only the symptoms of neurodegeneration and, at best, result in modest, short-term …
D Schenk - New York Times, 2002 - researchgate.net
The agents that are available at present for the management of Alzheimer's disease treat only the symptoms of neurodegeneration and, at best, result in modest, short-term …
D Schenk - Nature reviews. Neuroscience, 2002 - europepmc.org
Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
D Schenk - Nature reviews. Neuroscience, 2002 - pubmed.ncbi.nlm.nih.gov
Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Nat Rev Neurosci. 2002 …